India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User (Pharmaceutical/Biotechnology Companies, CRO) By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture), By Region, Competition Forecast & Opportunities, FY 2026
India stem cell market was valued at USD 0.47 Billion in 2019 and is projected to grow at around 13% CAGR during FY 2021 – FY 2026. Continuous advancements in tissue engineering is one of the prime factors boosting India stem cell market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of stem cell market during the forecast years. Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of India stem cell market over the next five years. India stem cell market is segmented based on product type, application, technology, end user and region.Based on product type, the market can be categorized into adult, induced pluripotent, human embryonic and others.
Out of these, the adult stem cells segment dominated the market until FY 2020 and is further expected to maintain its leading position in the market during the forecast period as well on account of reduced contamination risk associated with sub-culturing.Moreover, its compatibility with the human body is expected to drive the segment growth over the coming years.
Additionally, less requirement for production labor is boosting the growth of adult stem cells segment. Major players operating in India stem cell market include Thermofisher Scientific India Pvt. Ltd., Pluristem Technologies Ltd., Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd., Merck Lifescience Pvt. Ltd., Cordlife India Pvt. Ltd., LifeCell International Pvt. Ltd., StemCyte India Therapeutics Private Limited, Stempeutics Research Private Limited, ReeLabs Private Limited, among others. The companies are focussing on extensive research and developments activities in order to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.
• To analyze and forecast the market size of India stem cell market. • To classify and forecast India stem cell market based on product type, application, technology, end user and regional distribution. • To identify drivers and challenges for India stem cell market. • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India stem cell market. • To identify and analyze the profile of leading players operating in India stem cell market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of companies across the country.
Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.
Through this technique, the analyst could include the companies which could not be identified due to the limitations of secondary research. The analyst examined the companies, distribution channels and presence of all major players across the country. The analyst calculated the market size of India stem cell market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.
Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.
Key Target Audience:
• Stem cell companies, medical research institutes and other stakeholders • Government bodies such as regulating authorities and policy makers • Organizations, forums and alliances related to stem cell • Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, India stem cell market has been segmented into following categories, in addition to the industry trends which have also been detailed below: • Market, By Product Type: o Adult o Induced Pluripotent o Human Embryonic o Others
• Market, By Application: o Regenerative Medicine o Drug Discovery & Development • Market, By Technology: o Cell Acquisition o Cell Production o Cryopreservation o Expansion & Subculture • Market, By End User: o Pharmaceutical/Biotechnology Companies o CRO • Market, By Region: o North o East o West o South
Company Profiles: Detailed analysis of the major companies present in India stem cell market.
With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Dec 2020
Major players in the vascular endothelial growth factor (VEGF) inhibitor market are Pfizer, Amgen, Roche, Xbrane Biopharma AB, Genentech Inc., AstraZeneca plc, Bayer AG, Eli Lilly and Company and Allergan plc. The global vascular endothelial growth factor (VEGF) inhibitor market is expected to decline from $0.31 billion in 2019 to $0.28...
The North America Medical Thawing System Market would witness market growth of 9.8% CAGR during the forecast period (2020-2026). Thawing can be considered as a process of taking a frozen item from frozen to a temperature (generally above 00C) where there is no remaining ice viz. defrosting. Thawing is frequently considered as merely...
Global Hospital Care Partnering 2014 to 2020 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The Asia Pacific Medical Thawing System Market would witness market growth of 12% CAGR during the forecast period (2020-2026). The region comprises of growing economies, significantly China, India, and Japan. These nations consist of a huge number of patients with a high chronic disease rate. A rise in the number of chronic diseases...
The global oxidative stress assay market grew at a CAGR of around 8% during 2014-2019. Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the enzymes market are Sanofi, AbbVie Inc., Alexion Pharmaceuticals Inc, Horizon Pharma, Allergan plc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences and Roche Holdings AG. The global enzymes market is expected to decline from $7.98 billion in 2019 to $7.81 billion in 2020 at a compound annual growth rate...
KEY FINDINGS The global pharmaceutical filtration market is projected to register a CAGR of 8.48% during the forecast period, 2021-2028. The increasing production of large molecules and biologics, development in the biopharmaceutical industry, and rising healthcare expenditure, are among the factors estimated to contribute...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.